Unlike conventional techniques that require puncturing a lymph node or inserting a catheter (B, C), the lymphatic system can ...

Clariscan, approved in more than 55 countries globally with over four million patient doses shipped, is now FDA-approved in the U.S. Expands the GE Healthcare portfolio of contrast media products “The ...

ANNAPOLIS, MD, UNITED STATES, March 5, 2026 /EINPresswire.com/ — RadSite™, a leading accreditation agency promoting safety and quality in imaging, will host a ...

Magnetic resonance imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated for its non-ionizing and non-invasive nature. With nearly 40% of MRI procedures requiring contrast ...

The FDA has approved Bracco’s gadopiclenol-based contrast agent, Vueway, for IV MRI imaging in neonates and infants. Vueway is a macrocyclic gadolinium-based contrast agent that delivers effective ...

CHALFONT ST GILES, England--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA) has approved Clariscan™, a macrocyclic, ionic, gadolinium-based, MRI contrast agent, expanding the GE ...

This webinar will clarify who may administer contrast, what level of supervision is required, and how imaging suppliers can remain compliant while protecting patient safety.” — Eliot Siegel, MD, Chair ...